SC
ALVO icon

Swan Capital’s Alvotech ALVO Stock Holding History

Swan Capital’s Portfolio ALVO Stock Details ALVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$819 – 512
2025
Q3 		$819 Buy
+100
New +$853 ﹤0.01% 407

Other funds holding ALVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LC
Littlejohn & Co Greenwich, Connecticut $106M AUM 7.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Swan Capital's ALVO Position: Q4 2025 in Review

Swan Capital sold out of Alvotech (ALVO) in Q4 2025, closing a stake of 100 shares — an estimated $819 sold.

Swan Capital first reported a position in ALVO in Q3 2025 and held it in 1 quarter. The position peaked at $819 in Q3 2025. 49 funds tracked by Wall St. Rank hold ALVO as of Q4 2025.

  • Swan Capital reported no remaining Alvotech position as of Q4 2025 after selling out during the quarter.
  • Swan Capital sold 100 Alvotech shares in Q4 2025, an estimated $819.
  • Swan Capital first reported a position in Alvotech in Q3 2025 and held it in 1 quarter.
  • Swan Capital's Alvotech position peaked at $819 in Q3 2025.
  • 49 funds tracked by Wall St. Rank held Alvotech as of Q4 2025.

Based on Swan Capital's 13F filing for Q4 2025, filed 12 Feb 2026.